The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 06, 2024
Filed:
Apr. 08, 2022
Applicant:
Azurity Pharmaceuticals, Inc., Woburn, MA (US);
Inventors:
Scott Brauer, Harrisonville, MO (US);
Gerold L. Mosher, Kansas City, MO (US);
Assignee:
AZURITY PHARMACEUTICALS, INC., Woburn, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 37/00 (2006.01); A01N 25/00 (2006.01); A01N 37/12 (2006.01); A01N 37/44 (2006.01); A61K 9/08 (2006.01); A61K 31/215 (2006.01); A61K 31/24 (2006.01); A61K 31/4422 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/34 (2017.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4422 (2013.01); A61K 9/08 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/34 (2013.01); A61K 47/38 (2013.01);
Abstract
Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).